|
KU.dk - According to trials, a new anti-obesity weight loss drug, Tesofensine, which may be launched on the world market in a few years, can produce weight loss twice that of currently approved obesity drugs. The Danish company Neurosearch and a number of researchers at the Faculty of Life Sciences at University of Copenhagen are [...]
|
Write a comment:
|